No RSABE [Regulatives / Guidelines]
Hi Helmut,
Actually one of my friend recently did this study and according to him he is getting ISCV around 32% for one of the partial AUCs and the upper limit of T/R ratio for that parameter is 127%. And he planning to use scaled approach.
One more thing for one of the parameter he is getting σ²D >0.03 and the T/R ratio within 80 to 125 (borderline pass). How to justify here ?
(I dont know how he completed this study in one month)
Actually one of my friend recently did this study and according to him he is getting ISCV around 32% for one of the partial AUCs and the upper limit of T/R ratio for that parameter is 127%. And he planning to use scaled approach.
One more thing for one of the parameter he is getting σ²D >0.03 and the T/R ratio within 80 to 125 (borderline pass). How to justify here ?

(I dont know how he completed this study in one month)
—
Kumar Naidu
Kumar Naidu
Complete thread:
- Draft FDA guidance on Methylphenidate Hydrochloride kumarnaidu 2014-11-10 08:16
- Five PK metrics + S×F interaction Helmut 2014-11-10 13:57
- Five PK metrics + S×F interaction AngusMcLean 2014-11-11 19:26
- Five PK metrics + S×F interaction jag009 2014-11-16 03:39
- Acceptance limit for the upper 95% confidence bound? Helmut 2014-11-17 12:49
- Acceptance limit for the upper 95% confidence bound? jag009 2014-11-17 17:29
- Quoting László Helmut 2014-11-18 03:56
- Acceptance limit for the upper 95% confidence bound? AngusMcLean 2014-11-19 13:28
- Acceptance limit for the upper 95% confidence bound? jag009 2014-11-17 17:29
- Acceptance limit for the upper 95% confidence bound? Helmut 2014-11-17 12:49
- Five PK metrics + S×F interaction kumarnaidu 2014-12-09 08:36
- Five PK metrics + S×F interaction drgunasakaran1 2014-11-10 18:29
- Five PK metrics + S×F interaction jag009 2014-11-11 18:04
- Five PK metrics + S×F interaction AngusMcLean 2014-11-11 19:22
- Five PK metrics + S×F interaction jag009 2014-11-11 20:08
- Tada! jag009 2014-11-13 20:17
- Tada! AngusMcLean 2014-11-13 23:06
- Tada! nobody 2014-11-19 09:30
- Tada! AngusMcLean 2014-11-19 13:42
- Tada! nobody 2014-11-19 13:55
- ABEL Helmut 2014-11-19 15:44
- ABEL nobody 2014-11-19 16:05
- ABEL Helmut 2014-11-19 16:59
- ABEL nobody 2014-11-19 17:10
- ABEL Helmut 2014-11-19 17:16
- ABEL AngusMcLean 2014-11-19 17:45
- Difficult formulations Helmut 2014-11-19 20:15
- Difficult formulations nobody 2014-11-19 21:04
- Difficult formulations Helmut 2014-11-19 21:49
- Difficult formulations nobody 2014-11-19 21:04
- Difficult formulations Helmut 2014-11-19 20:15
- ABEL nobody 2014-11-19 17:10
- ABEL Helmut 2014-11-19 16:59
- ABEL nobody 2014-11-19 16:05
- ABEL Helmut 2014-11-19 15:44
- Tada! nobody 2014-11-19 13:55
- Tada! AngusMcLean 2014-11-19 13:42
- Tada! nobody 2014-11-19 09:30
- Tada! AngusMcLean 2014-11-13 23:06
- Tada! jag009 2014-11-13 20:17
- Five PK metrics + S×F interaction jag009 2014-11-11 20:08
- Five PK metrics + S×F interaction Helmut 2014-11-10 13:57
